Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 2/20 | 1.00 |
| ▸ | FABP4 | P15090 | 2/20 | 1.00 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.50 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.48 |
| ▸ | EIF4A3 | P38919 | 4/20 | 0.40 |
| ▸ | LDHA | P00338 | 2/20 | 0.39 |
| ▸ | LDHB | P07195 | 2/20 | 0.39 |
| ▸ | RXRA | P19793 | 2/20 | 0.38 |
| ▸ | RXRB | P28702 | 1/20 | 0.38 |
| ▸ | RXRG | P48443 | 1/20 | 0.38 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.36 |
| ▸ | ALB | P02768 | 3/20 | 0.36 |
| ▸ | RARG | P13631 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17311830 | 0.98 | FABP3 (0.96) | FABP3FABP4FABP5GABRA1GABRB2 | |
| SCHEMBL16148313 | 0.88 | FABP3 (0.78) | FABP3FABP4FABP5GABRA1GABRB2 | |
| SCHEMBL28708940 | 0.88 | FABP3 (0.78) | FABP3FABP4FABP5GABRA1GABRB2 | |
| SCHEMBL20274264 | 0.85 | FABP3 (0.72) | FABP3FABP4FABP5GABRA1GABRB2 | |
| SCHEMBL19610481 | 0.84 | FABP3 (0.72) | FABP3FABP4GABRA1EIF4A3LDHA | |
| SCHEMBL2383444 | 0.82 | FABP4 (0.69) | FABP3FABP4FABP5GABRA1GABRB2 | |
| SCHEMBL17323547 | 0.82 | FABP3 (0.69) | FABP3FABP4GABRA1LDHALDHB | |
| SCHEMBL14273020 | 0.82 | FABP3 (0.69) | FABP3FABP4GABRA1LDHALDHB | |
| SCHEMBL446680 | 0.82 | FABP4 (0.69) | FABP3FABP4FABP5GABRA1GABRB2 | |
| SCHEMBL7484474 | 0.80 | FABP4 (0.67) | FABP3FABP4FABP5GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116761598-A | Antiviral use of FABP4 modulating compounds | 新月生物科学 | 2023-09-15 | — | — | CN | claimed |
| US-20230255933-A1 | ANTIVIRAL USE OF FABP4 MODULATING COMPOUNDS | CRESCENTA BIOSCIENCES (US) | 2023-08-17 | — | — | US | claimed |
| US-20230241025-A1 | ANTIVIRAL USE OF FABP4 MODULATING COMPOUNDS | CRESCENTA BIOSCIENCES (US) | 2023-08-03 | — | — | US | claimed |
| EP-4175647-A1 | ANTIVIRAL USE OF FABP4 MODULATING COMPOUNDS | Crescenta Biosciences (US) | 2023-05-10 | — | — | EP | claimed |
| CN-112300061-B | Preparation method of nitrogen-containing heterocyclic diaryl ketone compound | 大连理工大学 | 2022-02-18 | — | — | CN | claimed |
| WO-2022010951-A1 | ANTIVIRAL USE OF FABP4 MODULATING COMPOUNDS | CRESCENTA BIOSCIENCES (US) | 2022-01-13 | — | — | WO | claimed |
| CN-112300061-A | Preparation method of nitrogen-containing heterocyclic diaryl ketone compound | 大连理工大学 | 2021-02-02 | — | — | CN | claimed |
| CN-107056587-B | Method for synthesizing L-menthol | 福建青松股份有限公司 | 2020-06-05 | — | — | CN | claimed |
| CN-101003456-B | Method for preparing Beta, Gamma unsaturated ester | CHINA PETROCHEMICAL CORP | 2010-10-06 | — | — | CN | claimed |
| CN-101003456-A | Method for preparing Beta, Gamma unsaturated ester | CHINA PETROCHEMICAL CORP (CN) | 2007-07-25 | — | — | CN | claimed |
| US-6010975-A | Catalyst composition for preparing 3-pentenoic ester from butadiene | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2000-01-04 | — | — | US | claimed |
| CN-121732148-A | Water-resistant low-temperature catalyst and preparation method and application thereof | 河北工业大学 | 2026-03-27 | — | — | CN | disclosed |
| EP-4658713-A1 | METHOD FOR DEGRADING AND RECYCLING A POLYURETHANE AND THE DEGRADATION PRODUCT THEREOF | Covestro Deutschland AG (DE) | 2025-12-10 | — | — | EP | disclosed |
| CN-120004802-A | Method for synthesizing N-alkyl substituted 3, 5-dimethylpyrazole compound by one-pot method | 四川轻化工大学 | 2025-05-16 | — | — | CN | disclosed |
| CN-119432073-A | Resin composition | 味之素株式会社 | 2025-02-14 | — | — | CN | disclosed |
| US-5158936-A | Treating or prevention of tissue damage, inflammation, bone resporpption and muscular dystrophy | SYNTEX (U.S.A.) INC. (US) | 1992-10-27 | — | — | US | disclosed |
| US-5055451-A | Prevent tissue damage | SYNTEX INC. (US) | 1991-10-08 | — | — | US | disclosed |
| EP-0272671-A2 | Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors | SANDOZ LTD. (CH) | 1988-06-29 | — | — | EP | disclosed |
| US-4017540-A | INSECTICIDES, MITICIDES | THE UPJOHN COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
| US-3932661-A | Anthelmintic methods employing benzoyl chloride phenylhydrazones | THE UPJOHN COMPANY (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230241025-A1 | ANTIVIRAL USE OF FABP4 MODULATING COMPOUNDS | FABP1, FABP4, FABP5 | FABP3 4/4885FABP4 2/4885FABP5 3/4885 |
| US-20230255933-A1 | ANTIVIRAL USE OF FABP4 MODULATING COMPOUNDS | FABP1, FABP4, FABP5 | FABP3 4/4885FABP4 2/4885FABP5 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.